Tyra Biosciences (TYRA) Other Non Operating Income (2022 - 2023)

Tyra Biosciences (TYRA) reported Other Non Operating Income of -$5000.0 for Q3 2023, down 200.0% on a YoY basis from $5000.0 in Q3 2022, and down 200.0% quarter-over-quarter from $5000.0 in Q3 2022.

Tyra Biosciences (TYRA) Other Non Operating Income (2022 - 2023) Analysis & Trends

Tyra Biosciences has reported Other Non Operating Income for 2 years, with the latest figure at -$5000.0 in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn -
7 Psyence Biomedical 229.39 Bn 229.38 Bn -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn
9 Abivax 90.15 Bn 90.15 Bn -
10 Tyra Biosciences 1.67 Bn 1.67 Bn -

Historic Data

Download Data
DateValue
Sep 30, 2023 -5,000.00
Sep 30, 2022 5,000.00